94198-9
LaboratoryDPYD gene full mutation analysis in Blood or Tissue by Sequencing
Definition
The test includes full sequence analysis of exons and intron/exon boundaries of all 23 exons in the DPYD gene. Testing may be performed to identifying individuals at increased risk of toxicity when considering 5-fluorouracil (5-FU) and capecitabine chemotherapy treatment. Variations detected in the DPYD gene are also associated with dihydropyrimidine dehydrogenase (DPD) deficiency.
LOINC 6-Axis Classification
Component
DPYD gene full mutation analysis
Property
Find
Time Aspect
Pt
System
Bld/Tiss
Scale Type
Doc
Method Type
Sequencing
Details
Class
MOLPATH.PHARMG
Order/Observation
Both
Short Name
DPYD gene Full Mut Anl Bld/T Seq
Display Name
DPYD gene full mutation analysis Sequencing Doc (Bld/Tiss)
Related Names
Frequently Asked Questions
What is LOINC code 94198-9?
LOINC code 94198-9 identifies "DPYD gene full mutation analysis in Blood or Tissue by Sequencing". The test includes full sequence analysis of exons and intron/exon boundaries of all 23 exons in the DPYD gene. Testing may be performed to identifying individuals at increased risk of toxicity when considering 5-fluorouracil (5-FU) and capecitabine chemotherapy treatment. Variations detected in the DPYD gene are also associated with dihydropyrimidine dehydrogenase (DPD) deficiency.
What does 94198-9 measure?
This code measures DPYD gene full mutation analysis in Bld/Tiss. It belongs to the MOLPATH.PHARMG class in the LOINC classification.
What is LOINC?
LOINC (Logical Observation Identifiers Names and Codes) is a universal standard for identifying laboratory and clinical observations. It is maintained by the Regenstrief Institute and used worldwide for health data exchange.